Aurobindo Splits Out Biosimilars Business

Firm Upbeat On Outlook As It Seeks FDA Desk Reviews For Three Units

 
• By Vibha Ravi
  
Business growth
Aurobindo Looks For Growth As It Carves Out Biologics Business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business